Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study)
Küçük Resim Yok
Tarih
2022
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Lippincott Williams and Wilkins
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
[Abstract Not Available]
Açıklama
Anahtar Kelimeler
HER2PATH Study, Breast Cancer, Analysis of Pathologic
Kaynak
Journal of Clinical Oncology
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
40
Sayı
16
Künye
Bilici, A., Ölmez, Ö. F., Sezer, A., Öksüzoğlu, B., Kaplan, M. A., Karadurmuş, N. ... Helvacı, K. (2022). Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study). Journal of Clinical Oncology.
